PARIS, Feb 7 (Reuters) - L'Oreal has taken

stakes in clinics in China and North America in order to observe

and understand the medical aesthetics market, L'Oreal CEO

Nicolas Hieronimus said in an earnings call on Friday.

The company had announced in August the acquisition of a 10%

stake in Swiss skin care firm Galderma.

Hieronimus added that L'Oreal would be entering the

nutricosmetics market with a new product and said more would be

coming.